Back to All Studies

Cats with heart disease are prone to the formation of blood clots, which can travel to the aorta and cause an interruption in blood flow to the hind legs (thromboembolism) with devastating consequences. Researchers will compare the efficacy of the novel drug rivaroxaban to the efficacy of the standard-of-care drug clopidogrel, in preventing the formation of recurrent thromboembolisms. Information gained from this study will help researchers improve treatments and clinical management strategies to delay or prevent often-fatal clotting complications in cats with heart disease.

Study ID
D16FE-015
Study Status
Active
Start Date
10/01/2015
Grant amount awarded
$179,952
Grant recipient
The University of Georgia
Study country
United States
Investigator
Benjamin M. Brainard, VMD
Study category
Cardiovascular